ApconiX Welcomes Phumzile Sikakana to The Team.

ApconiX is delighted to welcome Phumzile Sikakana who joins us straight from University.  Phum, an enthusiastic new masters graduate will work with our team of experienced scientists on a variety of projects, including target safety reviews and in the ion channel screening laboratory, helping our clients make better decisions on drug safety.

Phum studied Biomedical Sciences at Cardiff University before completing her masters at Sheffield University following research into “The role of the phosphoinositide (PI) 5-kinase PIKfyve in phagosome maturation and killing, using the amoeba and model phagocyte Dictyostelium discoideum”.  Phum recently heard that she had been awarded a distinction for her masters degree.

A keen sports woman, Phum swam for Yorkshire until she was 16.  She started playing rugby when she joined Cardiff University and is hoping to continue playing, now she has moved to the Northwest.

Phum spent two summers in American Camp coaching 6 to 16-year olds.  Rocketry (the design and building of model rockets) was also on the curriculum.

“There will always be a need for new drugs and drug safety is such an important aspect of drug discovery. I am very interested in drug safety; it is a great to have the opportunity to explore various avenues all within the same company,” Phum commented.

Professor Ruth Roberts added, “I know Phum will be a great asset to the company.  We have grown significantly this year but bringing Phum in is not just about new resources to meet demand.  We are, as a company, keen to provide opportunities to young scientists and help the new generation of scientific minds grow and develop.”

By |2018-11-30T09:11:38+00:00December 5th, 2018|Target Safety Assessments, Careers|Comments Off on ApconiX Welcomes Phumzile Sikakana to The Team.

About the Author:

Professor Ruth A Roberts, PhD, ATS, FBTS, ERT, FRSB, FRCPath Director and Cofounder, ApconiX, UK and Chair and Director of Drug Discovery, University of Birmingham, UK Ruth is chair of drug discovery at Birmingham University, UK and Cofounder of ApconiX, an integrated toxicology and ion channel company that brings together a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development experience. Previously, Ruth was Global Head of Regulatory Safety at AstraZeneca and Director of Toxicology for Aventis. Ruth is an established science professional bringing rigorous expert thinking to toxicology, drug discovery and drug development. With >140 publications in peer reviewed journals, she is focused on reducing attrition attributable to safety and toxicity. A former president of the British Toxicology Society, former president of EUROTOX, former secretary to SOT and president elect of the Academy of Toxicological Sciences, Ruth was the recipient of the SOT Achievement award in 2002, the EUROTOX Bo Holmstedt Award in 2009 and the SOT Founders award in 2018 for outstanding leadership in toxicology.